Xvivo Perfusion AB (publ) (STO:XVIVO)
187.50
+1.50 (0.81%)
At close: Feb 27, 2026
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 5.91 billion as of February 27, 2026. Its market cap has decreased by -60.32% in one year.
Market Cap
5.91B
Enterprise Value
5.74B
Revenue
812.17M
Ranking
n/a
PE Ratio
234.72
Stock Price
187.50
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 5.91B, an increase of 1,488.99%. That is a compound annual growth rate of 22.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedCap AB | 6.97B |
| CellaVision AB | 3.57B |
| Vitrolife AB | 12.26B |
| Nolato AB | 13.90B |
| Elekta AB | 21.76B |
| BICO Group AB | 1.27B |
| Paxman AB | 1.19B |
| Sectra AB | 34.80B |